Lyell Immunopharma Stock Forecast - Daily Balance Of Power

LYEL Stock  USD 0.65  0.04  6.51%   
Lyell Stock Forecast is based on your current time horizon. Although Lyell Immunopharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Lyell Immunopharma's systematic risk associated with finding meaningful patterns of Lyell Immunopharma fundamentals over time.
  
The value of Payables Turnover is estimated to slide to 2.54. The value of Fixed Asset Turnover is estimated to slide to 0.0009. Common Stock Shares Outstanding is expected to rise to about 271.5 M this year, although the value of Net Loss will most likely fall to (173 M).
On March 28, 2024 Lyell Immunopharma had Daily Balance Of Power of 0.7917. Balance of Power indicator (or BOP) measures the strength of Lyell Immunopharma market sensitivity to bulls and bears. It estimates the ability of Lyell Immunopharma buyers and sellers to push price to an extreme high or extreme low level. As a result, by monitoring Lyell Immunopharma Balance of Power indicator one can determine a trend of the price direction.
Check Lyell Immunopharma VolatilityBacktest Lyell ImmunopharmaTrend Details  

Lyell Immunopharma Trading Date Momentum

On April 01 2024 Lyell Immunopharma was traded for  2.18  at the closing time. The top price for the day was 2.28  and the lowest listed price was  2.07 . The trading volume for the day was 1 M. The trading history from April 1, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.24% . The trading delta at closing time against the current closing price is 4.04% .
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Lyell Immunopharma to competition

Other Forecasting Options for Lyell Immunopharma

For every potential investor in Lyell, whether a beginner or expert, Lyell Immunopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Lyell Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Lyell. Basic forecasting techniques help filter out the noise by identifying Lyell Immunopharma's price trends.

View Lyell Immunopharma Related Equities

 Risk & Return  Correlation

Lyell Immunopharma Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Lyell Immunopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Lyell Immunopharma's current price.

Lyell Immunopharma Market Strength Events

Market strength indicators help investors to evaluate how Lyell Immunopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lyell Immunopharma shares will generate the highest return on investment. By undertsting and applying Lyell Immunopharma stock market strength indicators, traders can identify Lyell Immunopharma entry and exit signals to maximize returns.

Lyell Immunopharma Risk Indicators

The analysis of Lyell Immunopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Lyell Immunopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting lyell stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Lyell Immunopharma is a strong investment it is important to analyze Lyell Immunopharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lyell Immunopharma's future performance. For an informed investment choice regarding Lyell Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Lyell Immunopharma to cross-verify your projections.
For more information on how to buy Lyell Stock please use our How to buy in Lyell Stock guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lyell Immunopharma. If investors know Lyell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lyell Immunopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.79)
Quarterly Revenue Growth
0.36
Return On Assets
(0.19)
Return On Equity
(0.33)
The market value of Lyell Immunopharma is measured differently than its book value, which is the value of Lyell that is recorded on the company's balance sheet. Investors also form their own opinion of Lyell Immunopharma's value that differs from its market value or its book value, called intrinsic value, which is Lyell Immunopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lyell Immunopharma's market value can be influenced by many factors that don't directly affect Lyell Immunopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lyell Immunopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lyell Immunopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lyell Immunopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.